Prevention of Prostate Cancer by Androgens: Experimental Paradox or Clinical Reality
- 30 September 2004
- journal article
- review article
- Published by Elsevier in European Urology
- Vol. 46 (3) , 285-295
- https://doi.org/10.1016/j.eururo.2004.04.012
Abstract
No abstract availableKeywords
This publication has 56 references indexed in Scilit:
- Molecular determinants of resistance to antiandrogen therapyNature Medicine, 2003
- Vitamin D and androgen regulation of prostatic growthJournal of Cellular Biochemistry, 2003
- Reduced circulating androgen bioactivity in patients with prostate cancerThe Prostate, 2003
- Effects of 1,25‐dihydroxyvitamin D3 on the distribution of androgen and vitamin D receptors in human prostate neonatal epithelial cellsJournal of Cellular Biochemistry, 2002
- Association between prostate cancer and serum testosterone levelsThe Prostate, 2002
- Both retinoids and androgens are required to maintain or promote functional differentiation in reaggregation cultures of human prostate epithelial cellsThe Prostate, 2002
- Androgen-Driven Prostate Epithelial Cell Proliferation and Differentiation in Vivo Involve the Regulation of p27Molecular Endocrinology, 2001
- Involvement of p27Kip1 in G1 arrest by high dose 5α-dihydrotestosterone in LNCaP human prostate cancer cellsOncogene, 2000
- Two Androgen Response Regions Cooperate in Steroid Hormone Regulated Activity of the Prostate-specific Antigen PromoterJournal of Biological Chemistry, 1996
- Heparin-binding keratinocyte growth factor is a candidate stromal-to- epithelial-cell andromedinMolecular Endocrinology, 1992